Skip to Content

Drospirenone / ethinyl estradiol / levomefolate calcium Pregnancy and Breastfeeding Warnings

Drospirenone / ethinyl estradiol / levomefolate calcium is also known as: Beyaz, Rajani, Safyral, Tydemy

Medically reviewed on October 16, 2017

Drospirenone / ethinyl estradiol / levomefolate calcium Pregnancy Warnings

Drospirenone/ethinyl estradiol/levomefolate has been assigned to pregnancy category X by the FDA. Oral contraceptive combinations are contraindicated for use during pregnancy.

See references

Drospirenone / ethinyl estradiol / levomefolate calcium Breastfeeding Warnings

Drospirenone/ethinyl estradiol/levomefolate is excreted in human breast milk. Jaundice and breast enlargement have been reported in infants exposed to steroid contraceptives excreted in human milk. Studies to date indicate there is no adverse effect of folate on nursing infants. The manufacturer suggests that other forms of contraception be used if possible until the infant has been weaned from the mother.

See references

References for pregnancy information

  1. "Product Information. Beyaz (drospirenone/ethinyl estradiol/levomefolate)." Bayer Pharmaceutical Inc, West Haven, CT.

References for breastfeeding information

  1. "Product Information. Beyaz (drospirenone/ethinyl estradiol/levomefolate)." Bayer Pharmaceutical Inc, West Haven, CT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide